Company's first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammationNovel ...

Title: ZW1528, a Bispecific Antibody Targeting IL-4Ra and IL-33, Potently Inhibits Key Mediators of Airway Inflammation ...

Cellular agriculture represents a groundbreaking frontier in food production technology, with the potential to revolutionize the way we generate ...

Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

PDS Biotechnology Corp (PDSB) reports reduced net loss and strategic clinical trial progress, despite ongoing financial hurdles.